25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Creative Medical Technology Holdings Inc
Buy, Hold or Sell?

Let's analyze Creative Medical Technology Holdings Inc together

I guess you are interested in Creative Medical Technology Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Creative Medical Technology Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Creative Medical Technology Holdings Inc

I send you an email if I find something interesting about Creative Medical Technology Holdings Inc.

1. Quick Overview

1.1. Quick analysis of Creative Medical Technology Holdings Inc (30 sec.)










1.2. What can you expect buying and holding a share of Creative Medical Technology Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.7%

What is your share worth?

Current worth
$3.75
Expected worth in 1 year
$0.58
How sure are you?
30.8%

+ What do you gain per year?

Total Gains per Share
$-3.17
Return On Investment
-130.3%

For what price can you sell your share?

Current Price per Share
$2.43
Expected price per share
$2.4101 - $2.98
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Creative Medical Technology Holdings Inc (5 min.)




Live pricePrice per Share (EOD)
$2.43
Intrinsic Value Per Share
$-45.16 - $-22.53
Total Value Per Share
$-41.41 - $-18.78

2.2. Growth of Creative Medical Technology Holdings Inc (5 min.)




Is Creative Medical Technology Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$6.5m$14.1m-$5.6m-67.5%

How much money is Creative Medical Technology Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$2.4m$1m82.4%
Net Profit Margin-27,535.6%-14,328.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Creative Medical Technology Holdings Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#671 / 949

Most Revenue
#771 / 949

Most Profit
#258 / 949

Most Efficient
#911 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Creative Medical Technology Holdings Inc?

Welcome investor! Creative Medical Technology Holdings Inc's management wants to use your money to grow the business. In return you get a share of Creative Medical Technology Holdings Inc.

First you should know what it really means to hold a share of Creative Medical Technology Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of Creative Medical Technology Holdings Inc is $2.43. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Creative Medical Technology Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Creative Medical Technology Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.75. Based on the TTM, the Book Value Change Per Share is $-0.79 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Creative Medical Technology Holdings Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.59-24.5%-0.76-31.3%-1.41-58.1%-1.05-43.1%-0.83-34.3%
Usd Book Value Change Per Share-0.60-24.9%-0.79-32.6%-1.43-58.7%0.2911.9%0.104.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share-0.60-24.9%-0.79-32.6%-1.43-58.7%0.2912.0%0.104.1%
Usd Price Per Share3.10-4.19-2.61-1.73-0.91-
Price to Earnings Ratio-1.30--1.44--0.89--0.57--0.34-
Price-to-Total Gains Ratio-5.13--5.52--3.40--2.19--1.79-
Price to Book Ratio0.83-0.87-0.35-0.29-0.12-
Price-to-Total Gains Ratio-5.13--5.52--3.40--2.19--1.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.43
Number of shares411
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.790.29
Usd Total Gains Per Share-0.790.29
Gains per Quarter (411 shares)-325.30119.60
Gains per Year (411 shares)-1,301.19478.38
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1301-13113476468
20-2602-26125952946
30-3904-3913814271424
40-5205-52141019031902
50-6506-65151323792380
60-7807-78161628552858
70-9108-91171833303336
80-10410-104182138063814
90-11711-117192342824292
100-13012-130202647584770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%3.017.00.015.0%4.035.00.010.3%4.063.00.06.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%8.012.00.040.0%12.026.01.030.8%13.050.04.019.4%
Dividend per Share0.00.04.00.0%1.00.011.08.3%2.00.018.010.0%3.00.036.07.7%3.00.064.04.5%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%8.012.00.040.0%12.026.01.030.8%13.050.04.019.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Creative Medical Technology Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.604-0.791+31%-1.427+136%0.289-309%0.098-715%
Book Value Per Share--3.7504.825-22%8.080-54%2.743+37%0.728+415%
Current Ratio--19.13422.635-15%26.263-27%17.270+11%8.889+115%
Debt To Asset Ratio--0.0480.043+13%0.065-27%5.719-99%53.049-100%
Debt To Equity Ratio--0.0500.045+13%0.075-33%0.033+54%0.017+199%
Dividend Per Share----0%-0%0.002-100%0.002-100%
Enterprise Value--11349488.15715144458.314-25%18049939.331-37%6875700.101+65%3078960.841+269%
Eps---0.595-0.760+28%-1.412+137%-1.048+76%-0.834+40%
Ev To Ebitda Ratio---2.626-2.925+11%-3.038+16%inf+inf%inf+inf%
Ev To Sales Ratio--infinfnan%infnan%nannan%nannan%
Free Cash Flow Per Share---0.564-0.765+36%-1.390+147%-0.629+12%-0.372-34%
Free Cash Flow To Equity Per Share---0.578-0.828+43%-3.603+523%0.189-406%0.099-685%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---22.529--------
Intrinsic Value_10Y_min---45.159--------
Intrinsic Value_1Y_max---1.603--------
Intrinsic Value_1Y_min---4.029--------
Intrinsic Value_3Y_max---5.315--------
Intrinsic Value_3Y_min---12.607--------
Intrinsic Value_5Y_max---9.629--------
Intrinsic Value_5Y_min---21.669--------
Market Cap4248684.900-28%5419958.1577330249.064-26%4561697.581+19%3027665.201+79%1587451.545+241%
Net Profit Margin----275.3560%-143.2890%-120.5580%-124.4960%
Operating Margin----285.2400%-148.6800%-51.8160%-30.7700%
Operating Ratio---292.540-100%149.180-100%104.338-100%57.922-100%
Pb Ratio0.648-28%0.8270.869-5%0.351+136%0.295+181%0.122+578%
Pe Ratio-1.021+22%-1.303-1.442+11%-0.886-32%-0.571-56%-0.343-74%
Price Per Share2.430-28%3.1004.192-26%2.609+19%1.731+79%0.908+241%
Price To Free Cash Flow Ratio-1.078+22%-1.375-1.517+10%-0.951-31%-0.607-56%-0.344-75%
Price To Total Gains Ratio-4.022+22%-5.130-5.519+8%-3.404-34%-2.191-57%-1.788-65%
Quick Ratio--18.91930.735-38%39.472-52%21.504-12%11.059+71%
Return On Assets---0.151-0.153+1%-0.145-4%-2.551+1589%-5.175+3327%
Return On Equity---0.159-0.160+1%-0.164+3%-0.096-39%-0.049-69%
Total Gains Per Share---0.604-0.791+31%-1.427+136%0.291-308%0.100-701%
Usd Book Value--6557011.0008435714.750-22%14126979.250-54%4424546.450+48%1082138.615+506%
Usd Book Value Change Per Share---0.604-0.791+31%-1.427+136%0.289-309%0.098-715%
Usd Book Value Per Share--3.7504.825-22%8.080-54%2.743+37%0.728+415%
Usd Dividend Per Share----0%-0%0.002-100%0.002-100%
Usd Eps---0.595-0.760+28%-1.412+137%-1.048+76%-0.834+40%
Usd Free Cash Flow---985592.000-1336684.750+36%-2431034.000+147%-1111824.400+13%-657099.000-33%
Usd Free Cash Flow Per Share---0.564-0.765+36%-1.390+147%-0.629+12%-0.372-34%
Usd Free Cash Flow To Equity Per Share---0.578-0.828+43%-3.603+523%0.189-406%0.099-685%
Usd Market Cap4248684.900-28%5419958.1577330249.064-26%4561697.581+19%3027665.201+79%1587451.545+241%
Usd Price Per Share2.430-28%3.1004.192-26%2.609+19%1.731+79%0.908+241%
Usd Profit---1040135.000-1329495.250+28%-2425075.000+133%-2519136.500+142%-1741358.667+67%
Usd Revenue---3500.000-100%6150.000-100%15997.700-100%16047.538-100%
Usd Total Gains Per Share---0.604-0.791+31%-1.427+136%0.291-308%0.100-701%
 EOD+3 -5MRQTTM+19 -14YOY+22 -115Y+20 -1610Y+18 -18

3.3 Fundamental Score

Let's check the fundamental score of Creative Medical Technology Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.021
Price to Book Ratio (EOD)Between0-10.648
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than118.919
Current Ratio (MRQ)Greater than119.134
Debt to Asset Ratio (MRQ)Less than10.048
Debt to Equity Ratio (MRQ)Less than10.050
Return on Equity (MRQ)Greater than0.15-0.159
Return on Assets (MRQ)Greater than0.05-0.151
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Creative Medical Technology Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.376
Ma 20Greater thanMa 502.671
Ma 50Greater thanMa 1003.291
Ma 100Greater thanMa 2003.328
OpenGreater thanClose2.418
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Fundamental data was last updated by Penke on 2024-11-23 08:24:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Creative Medical Technology Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Creative Medical Technology Holdings Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Creative Medical Technology Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-27,535.6%+27,535.6%
TTM-27,535.6%YOY-14,328.9%-13,206.7%
TTM-27,535.6%5Y-12,055.8%-15,479.8%
5Y-12,055.8%10Y-12,449.6%+393.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--112.2%+112.2%
TTM-27,535.6%-221.4%-27,314.2%
YOY-14,328.9%-210.0%-14,118.9%
5Y-12,055.8%-342.2%-11,713.6%
10Y-12,449.6%-464.5%-11,985.1%
4.3.1.2. Return on Assets

Shows how efficient Creative Medical Technology Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Creative Medical Technology Holdings Inc to the Biotechnology industry mean.
  • -15.1% Return on Assets means that Creative Medical Technology Holdings Inc generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Creative Medical Technology Holdings Inc:

  • The MRQ is -15.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-15.3%+0.2%
TTM-15.3%YOY-14.5%-0.8%
TTM-15.3%5Y-255.1%+239.8%
5Y-255.1%10Y-517.5%+262.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.1%-11.3%-3.8%
TTM-15.3%-11.7%-3.6%
YOY-14.5%-11.3%-3.2%
5Y-255.1%-12.7%-242.4%
10Y-517.5%-14.1%-503.4%
4.3.1.3. Return on Equity

Shows how efficient Creative Medical Technology Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Creative Medical Technology Holdings Inc to the Biotechnology industry mean.
  • -15.9% Return on Equity means Creative Medical Technology Holdings Inc generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Creative Medical Technology Holdings Inc:

  • The MRQ is -15.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-16.0%+0.1%
TTM-16.0%YOY-16.4%+0.4%
TTM-16.0%5Y-9.6%-6.3%
5Y-9.6%10Y-4.9%-4.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%-14.2%-1.7%
TTM-16.0%-15.9%-0.1%
YOY-16.4%-14.3%-2.1%
5Y-9.6%-18.5%+8.9%
10Y-4.9%-19.3%+14.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Creative Medical Technology Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Creative Medical Technology Holdings Inc is operating .

  • Measures how much profit Creative Medical Technology Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Creative Medical Technology Holdings Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Creative Medical Technology Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-28,524.0%+28,524.0%
TTM-28,524.0%YOY-14,868.0%-13,655.9%
TTM-28,524.0%5Y-5,181.6%-23,342.4%
5Y-5,181.6%10Y-3,077.0%-2,104.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM-28,524.0%-310.7%-28,213.3%
YOY-14,868.0%-223.5%-14,644.5%
5Y-5,181.6%-387.1%-4,794.5%
10Y-3,077.0%-498.5%-2,578.5%
4.3.2.2. Operating Ratio

Measures how efficient Creative Medical Technology Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Creative Medical Technology Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM292.540-292.540
TTM292.540YOY149.180+143.359
TTM292.5405Y104.338+188.202
5Y104.33810Y57.922+46.416
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.465-2.465
TTM292.5403.253+289.287
YOY149.1803.298+145.882
5Y104.3384.788+99.550
10Y57.9226.494+51.428
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Creative Medical Technology Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Creative Medical Technology Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 19.13 means the company has $19.13 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Creative Medical Technology Holdings Inc:

  • The MRQ is 19.134. The company is very able to pay all its short-term debts. +2
  • The TTM is 22.635. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ19.134TTM22.635-3.502
TTM22.635YOY26.263-3.628
TTM22.6355Y17.270+5.365
5Y17.27010Y8.889+8.381
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.1343.637+15.497
TTM22.6353.890+18.745
YOY26.2634.666+21.597
5Y17.2705.953+11.317
10Y8.8896.277+2.612
4.4.3.2. Quick Ratio

Measures if Creative Medical Technology Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Creative Medical Technology Holdings Inc to the Biotechnology industry mean.
  • A Quick Ratio of 18.92 means the company can pay off $18.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Creative Medical Technology Holdings Inc:

  • The MRQ is 18.919. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 30.735. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ18.919TTM30.735-11.816
TTM30.735YOY39.472-8.737
TTM30.7355Y21.504+9.231
5Y21.50410Y11.059+10.445
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.9193.086+15.833
TTM30.7353.451+27.284
YOY39.4724.456+35.016
5Y21.5045.931+15.573
10Y11.0596.436+4.623
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Creative Medical Technology Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Creative Medical Technology Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Creative Medical Technology Holdings Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that Creative Medical Technology Holdings Inc assets are financed with 4.8% credit (debt) and the remaining percentage (100% - 4.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Creative Medical Technology Holdings Inc:

  • The MRQ is 0.048. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.043. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.048TTM0.043+0.005
TTM0.043YOY0.065-0.023
TTM0.0435Y5.719-5.676
5Y5.71910Y53.049-47.330
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0480.350-0.302
TTM0.0430.344-0.301
YOY0.0650.310-0.245
5Y5.7190.365+5.354
10Y53.0490.382+52.667
4.5.4.2. Debt to Equity Ratio

Measures if Creative Medical Technology Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Creative Medical Technology Holdings Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.0% means that company has $0.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Creative Medical Technology Holdings Inc:

  • The MRQ is 0.050. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.045. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.050TTM0.045+0.006
TTM0.045YOY0.075-0.031
TTM0.0455Y0.033+0.012
5Y0.03310Y0.017+0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0500.394-0.344
TTM0.0450.432-0.387
YOY0.0750.380-0.305
5Y0.0330.451-0.418
10Y0.0170.490-0.473
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Creative Medical Technology Holdings Inc generates.

  • Above 15 is considered overpriced but always compare Creative Medical Technology Holdings Inc to the Biotechnology industry mean.
  • A PE ratio of -1.30 means the investor is paying $-1.30 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Creative Medical Technology Holdings Inc:

  • The EOD is -1.021. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.303. Based on the earnings, the company is expensive. -2
  • The TTM is -1.442. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.021MRQ-1.303+0.282
MRQ-1.303TTM-1.442+0.140
TTM-1.442YOY-0.886-0.557
TTM-1.4425Y-0.571-0.871
5Y-0.57110Y-0.343-0.229
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.021-2.253+1.232
MRQ-1.303-2.411+1.108
TTM-1.442-3.149+1.707
YOY-0.886-3.274+2.388
5Y-0.571-6.143+5.572
10Y-0.343-6.785+6.442
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Creative Medical Technology Holdings Inc:

  • The EOD is -1.078. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.375. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.517. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.078MRQ-1.375+0.297
MRQ-1.375TTM-1.517+0.143
TTM-1.517YOY-0.951-0.566
TTM-1.5175Y-0.607-0.910
5Y-0.60710Y-0.344-0.263
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.078-3.009+1.931
MRQ-1.375-3.259+1.884
TTM-1.517-3.730+2.213
YOY-0.951-4.574+3.623
5Y-0.607-8.371+7.764
10Y-0.344-9.287+8.943
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Creative Medical Technology Holdings Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.83 means the investor is paying $0.83 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Creative Medical Technology Holdings Inc:

  • The EOD is 0.648. Based on the equity, the company is cheap. +2
  • The MRQ is 0.827. Based on the equity, the company is cheap. +2
  • The TTM is 0.869. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.648MRQ0.827-0.179
MRQ0.827TTM0.869-0.043
TTM0.869YOY0.351+0.519
TTM0.8695Y0.295+0.575
5Y0.29510Y0.122+0.173
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6481.979-1.331
MRQ0.8272.051-1.224
TTM0.8692.365-1.496
YOY0.3512.455-2.104
5Y0.2953.726-3.431
10Y0.1224.378-4.256
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Creative Medical Technology Holdings Inc.

4.8.1. Institutions holding Creative Medical Technology Holdings Inc

Institutions are holding 3.957% of the shares of Creative Medical Technology Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Aaron Wealth Advisors LLC1.11930.00721957000
2024-09-30Vanguard Group Inc1.008301762900
2024-06-30Two Sigma Advisers, LLC0.85790.000115000325627.7248
2024-06-30Two Sigma Investments LLC0.8470.000114809-89-0.5974
2024-06-30Tower Research Capital LLC0.12010.0001209941524.6437
2024-06-30Bank of America Corp0.007401292119.4444
2024-06-30Advisor Group Holdings, Inc.0.0058010110010000
2024-06-30Morgan Stanley - Brokerage Accounts0.002304000
2024-06-30Wells Fargo & Co000-11-100
2024-06-30Omers Administration Corp000-11000-100
2024-06-30UBS Group AG000-3064-100
2024-06-30Virtu Financial LLC000-16374-100
2024-06-30HRT FINANCIAL LLC000-13194-100
Total 3.96810.007569377-39940-57.6%

4.9.2. Funds holding Creative Medical Technology Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr1.00830.00011762900
2024-09-30Fidelity Extended Market Index0.4140.00017239-481-6.2306
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.05730100200
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.04620.000180720.2484
2024-09-30Fidelity Series Total Market Index0.0415072500
2024-09-30NT Ext Equity Mkt Idx Fd - L0.0403070500
2024-09-30Northern Trust Extended Eq Market Idx0.0403070500
2024-10-31State St US Extended Mkt Indx NL Cl C0.01430.000125000
2024-09-30Spartan Total Market Index Pool E0.0137024000
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0062010900
2024-06-30SSgA U.S. Total Market Index Strategy0.005901033041.0959
2024-09-30Spartan Extended Market Index Pool E0.0018031310
2024-09-30Fidelity U.S. Equity Index Ins Trust0.00101800
Total 1.69080.000429563-418-1.4%

5.3. Insider Transactions

Insiders are holding 2.103% of the shares of Creative Medical Technology Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-27Timothy WarbingtonBUY8004.44
2022-11-21Timothy WarbingtonBUY15004
2022-09-27Michael H FingerBUY2005
2022-09-27Timothy WarbingtonBUY20005
2022-09-21Timothy WarbingtonBUY30006.1
2022-06-14Michael H FingerBUY10007
2022-06-06Timothy WarbingtonBUY25009.2
2022-05-20Michael H FingerBUY65015
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets6,888
Total Liabilities331
Total Stockholder Equity6,557
 As reported
Total Liabilities 331
Total Stockholder Equity+ 6,557
Total Assets = 6,888

Assets

Total Assets6,888
Total Current Assets6,331
Long-term Assets556
Total Current Assets
Cash And Cash Equivalents 6,260
Inventory 3
Other Current Assets 68
Total Current Assets  (as reported)6,331
Total Current Assets  (calculated)6,331
+/-0
Long-term Assets
Intangible Assets 553
Long-term Assets Other 3
Long-term Assets  (as reported)556
Long-term Assets  (calculated)556
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities331
Long-term Liabilities0
Total Stockholder Equity6,557
Total Current Liabilities
Accounts payable 274
Other Current Liabilities 57
Total Current Liabilities  (as reported)331
Total Current Liabilities  (calculated)331
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -62,738
Accumulated Other Comprehensive Income -69,293
Other Stockholders Equity 138,587
Total Stockholder Equity (as reported)6,557
Total Stockholder Equity (calculated)6,557
+/- 0
Other
Cash and Short Term Investments 6,260
Common Stock Shares Outstanding 1,392
Liabilities and Stockholders Equity 6,888
Net Debt -6,260
Net Working Capital 6,001



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-30
> Total Assets 
0
36
0
0
13
2
2
1
0
3
0
0
0
0
0
0
4
3
2
1
1
2
2
0
0
0
1
1
1
1
1
1
1
0
122
137
323
196
300
211
203
291
279
356
477
477
358
330
531
531
443
425
718
872
732
3,132
11,268
9,734
23,434
22,468
19,186
15,229
14,127
12,514
10,715
9,620
7,990
6,888
6,8887,9909,62010,71512,51414,12715,22919,18622,46823,4349,73411,2683,132732872718425443531531330358477477356279291203211300196323137122011111110002211234000000301221300360
   > Total Current Assets 
0
36
0
0
13
2
2
1
0
3
0
0
0
0
0
0
4
3
2
1
1
2
2
0
0
0
1
1
1
1
1
1
1
0
26
33
222
98
104
21
18
112
105
187
314
314
205
183
94
94
40
39
98
275
159
2,578
10,737
9,226
22,949
22,006
18,747
14,814
13,735
12,044
10,271
9,205
7,604
6,331
6,3317,6049,20510,27112,04413,73514,81418,74722,00622,9499,22610,7372,57815927598394094941832053143141871051121821104982223326011111110002211234000000301221300360
       Cash And Cash Equivalents 
0
22
0
0
10
0
0
1
0
1
0
0
0
0
0
0
1
1
1
1
1
1
1
0
0
0
1
1
1
1
1
1
1
0
26
33
222
98
104
21
14
102
101
173
304
304
204
158
89
89
37
39
98
275
159
2,378
10,724
9,147
22,864
21,990
18,399
9,516
3,990
4,507
3,467
9,007
7,471
6,260
6,2607,4719,0073,4674,5073,9909,51618,39921,99022,8649,14710,7242,37815927598393789891582043043041731011021421104982223326011111110001111111000000101001000220
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,021
10,079
5,041
9,581
7,467
6,520
6,520
0
0
006,5206,5207,4679,5815,04110,0795,02100000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
10
5
14
10
10
1
25
6
6
1
0
6
0
0
0
2
0
0
-5,021
-10,079
0
0
0
0
0
0
0
0000000-10,079-5,0210020006016625110101451050000000000000000000000000000000000000090
       Other Current Assets 
0
5
0
0
2
1
1
0
0
3
0
0
0
0
0
0
3
2
1
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
0
65
65
5,021
10,417
246
154
61
277
191
129
68
681291912776115424610,4175,021656502000000000000000000000000000000000011001230000003001120050
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96
103
101
98
195
190
185
179
174
169
0
164
153
148
437
437
403
387
620
597
574
554
531
508
485
462
439
416
393
470
444
415
386
556
556386415444470393416439462485508531554574597620387403437437148153164016917417918519019598101103960000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96
103
101
98
195
190
185
179
174
169
164
164
153
148
437
437
403
387
620
597
574
551
528
505
482
459
436
413
390
467
441
412
382
553
55338241244146739041343645948250552855157459762038740343743714815316416416917417918519019598101103960000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
3
3
3
0
0
3
0
0
0
0
0
00000300333330000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
9
0
0
0
1
1
19
22
34
39
41
45
49
57
61
70
75
83
87
93
99
110
114
119
125
136
142
148
154
163
169
176
184
373
472
480
496
1,322
1,284
2,439
8,225
10,871
7,710
4,472
4,472
2,995
3,893
8,602
8,602
4,648
3,202
40,521
3,314
1,447
3,495
1,050
380
390
397
3,322
408
399
421
371
391
376
331
3313763913714213994083,3223973903801,0503,4951,4473,31440,5213,2024,6488,6028,6023,8932,9954,4724,4727,71010,8718,2252,4391,2841,3224964804723731841761691631541481421361251191141109993878375706157494541393422191100090
   > Total Current Liabilities 
0
9
0
0
0
1
1
19
22
34
39
41
45
49
57
61
70
75
83
87
93
99
110
114
119
125
136
142
148
154
163
169
176
158
304
446
454
469
1,314
1,267
2,435
8,221
10,871
7,710
4,472
4,472
2,995
3,893
8,602
8,602
4,648
3,202
40,521
3,314
1,447
3,495
1,050
380
390
397
3,322
408
399
421
371
391
376
331
3313763913714213994083,3223973903801,0503,4951,4473,31440,5213,2024,6488,6028,6023,8932,9954,4724,4727,71010,8718,2212,4351,2671,3144694544463041581761691631541481421361251191141109993878375706157494541393422191100090
       Short-term Debt 
0
0
0
0
0
0
0
16
22
32
37
38
45
49
53
59
6
67
75
79
85
89
100
107
111
117
124
132
137
144
150
158
163
141
66
116
100
100
274
381
513
509
365
339
682
682
1,070
896
1,062
1,062
1,047
909
789
327
222
2,743
0
0
14
14
14
14
14
14
14
14
14
0
0141414141414141414002,7432223277899091,0471,0621,0628961,07068268233936550951338127410010011666141163158150144137132124117111107100898579756765953494538373222160000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128
283
258
377
384
240
214
682
1,079
1,070
896
1,062
1,031
1,047
909
789
327
222
2,743
0
0
0
0
0
0
0
0
0
0
0
0
0000000000002,7432223277899091,0471,0311,0628961,0701,0796822142403843772582831280000000000000000000000000000000000000
       Accounts payable 
0
9
0
0
0
1
1
3
0
2
2
3
0
0
4
2
3
8
8
8
8
10
10
7
8
8
12
10
11
10
13
11
13
17
26
45
66
97
53
157
238
233
273
243
332
332
320
324
321
321
381
344
351
356
365
455
762
336
311
328
3,268
353
344
367
317
337
322
274
2743223373173673443533,268328311336762455365356351344381321321324320332332243273233238157539766452617131113101110128871010888832400322031100090
       Other Current Liabilities 
0
0
0
0
0
0
0
0
22
0
0
38
45
49
0
59
60
67
0
79
85
89
0
107
111
117
0
0
0
0
0
0
0
0
213
283
285
272
681
401
1,309
7,046
9,929
6,818
3,227
3,447
1,385
2,544
6,848
6,848
2,811
1,571
38,742
2,276
248
297
289
44
79
69
54
54
54
54
54
54
54
57
57545454545454546979442892972482,27638,7421,5712,8116,8486,8482,5441,3853,4473,2276,8189,9297,0461,30940168127228528321300000000117111107089857906760590494538002200000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
69
26
26
27
8
17
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
-363
762
336
311
328
3,268
353
0
0
0
0
0
0
0000003533,268328311336762-3630000000000000441782726266926000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
27
2
3
3
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000043322726000000000000000000000000000000000000
> Total Stockholder Equity
0
26
0
0
13
1
1
-18
-21
-31
-39
-41
-44
-48
-56
-61
-65
-72
-81
-86
-92
-98
-108
-114
-119
-125
-135
-141
-147
-153
-162
-169
-175
-184
-251
-335
-158
-300
-1,023
-1,073
-2,236
-7,934
-10,592
-7,354
-3,998
-3,995
-2,637
-3,563
-8,071
-8,071
-4,205
-2,776
-39,803
-2,443
-714
-363
10,218
9,354
23,044
22,071
15,865
14,822
13,729
12,092
10,344
9,229
7,613
6,557
6,5577,6139,22910,34412,09213,72914,82215,86522,07123,0449,35410,218-363-714-2,443-39,803-2,776-4,205-8,071-8,071-3,563-2,637-3,995-3,998-7,354-10,592-7,934-2,236-1,073-1,023-300-158-335-251-184-175-169-162-153-147-141-135-125-119-114-108-98-92-86-81-72-65-61-56-48-44-41-39-31-21-18111300260
   Common Stock
0
17
0
0
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
100
101
105
106
106
106
115
400
677
784
903
903
1,188
2,108
22
22
245
476
769
1,140
1,220
2
6
7
14
14
14
14
1
1
1
1
1
1
111111141414147621,2201,14076947624522222,1081,18890390378467740011510610610610510110018181818181818181818181818181818181818181818181818181818181800170
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income -69,293-1000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
128
0
0
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
154
6
136
504
604
767
769
1,075
2,678
6,172
10,875
0
12,181
14,139
14,699
0
17,468
19,212
20,015
21,316
30,001
34,560
38,434
53,879
54,170
69,644
69,653
69,662
69,672
69,693
69,511
69,441
69,367
69,310
138,587
138,58769,31069,36769,44169,51169,69369,67269,66269,65369,64454,17053,87938,43434,56030,00121,31620,01519,21217,468014,69914,13912,181010,8756,1722,6781,0757697676045041366154154154154154154154154154154154154154154154154154154154154154154154154154154154154154154001280



5.3. Balance Sheets

Currency in USD. All numbers in thousands.